Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Kromek lands five-year contract worth at least US$5.38mln

The contract is worth at least US$5,38mln, with revenue starting to flow through in the current financial year (to end-April).
Bone scan
As medtech companies move away from legacy diagnostic systems, CZT-based detectors will become a core technology

Shares in Kromek Group PLC (LON:KMK) opened higher after the radiation technology company announced a new five-year contract from an existing customer.

The customer, which operates in the bone mineral densitometry sector, intends to incorporate Kromek’s cadmium zinc telluride (CZT)-based detector modules in a new medical diagnostics product.

WATCH: Contract 'validates increasing traction of Kromek's CZT-based detectors'

Delivery on the contract, which is worth a minimum value of US$5.38m, is expected to begin in the current financial year, which runs to the end of April 2018.

Dr Arnab Basu, chief executive officer of Kromek, said the order validated the company’s belief that CZT-based detectors will become a core technology in the diagnostics industry.

Kromek expects to be one of the major suppliers to this segment, Dr Basu said.

“The agreement also demonstrates the strong relationships we build with our customers and the company's commitment to securing further contracts in the medical imaging sector," he added.

Kromek’s shares were up 2.2% at 29p.

--Updates for share price and video link--


View full KMK profile View Profile

Kromek Group PLC Timeline

Related Articles

August 20 2018
One of the orders will be fulfilled over the next 18 months, the other over the current financial year
Mobile and tablet
September 07 2018
Ethernity specialises in technology that helps data traffic move efficiently in huge quantities
Picture of XTEK's products
May 04 2018
Patersons' price target of $1.15 implies upside of 130% relative to XTEK's current share price.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use